
The Campbell's Company remains a Buy, offering a compelling valuation and a sustainable ~7% dividend yield despite persistent macro headwinds. CPB's cost-saving initiatives, portfolio rebalancing, and focus on Snacks position it for margin recovery and potential long-term re-rating as consumer conditions improve. Risks include intensifying private label competition, consumer weakness, and ongoing margin pressure, but CPB's strong balance sheet and investment-grade focus provide resilience.










